Michael Turner, general counsel and company secretary of innovation company Allied Minds, disposed of 112,491 ordinary shares in the firm at 118.54p on Wednesday.
Analysts at Credit Suisse slashed their target on shares of Allied Minds, telling clients they were still waiting for the commercial proof points from the company and pointed out its ongoing rate of 'cash burn'.
Mitie Group: Barclays upgrades to overweight with a target price of 180p.
Analysts at Numis upgraded their rating on intellectual property group Allied Minds on Thursday, highlighting the fact that the 15% drop in its net asset value per share over the last year was merely the result of a "further clean-up in the portfolio".
Sabre Insurance Group plc: Numis downgrades to add with a target price of 330.
Intellectual property commercialisation firm Allied Minds narrowed losses in its most recent trading year, boosted by rising revenues reductions in its financing costs.
Intellectual property commercialisation company Allied Minds has found two investors to take up $10.28m of the $22.8m convertible bridge facility commitment it was offering to one its its subsidiary companies.
Landsec: HSBC downgrades to Hold with a target price of 1081p.
Allied Minds reported good progress had been made across the group in the first half due to a strengthened team capitalising better on its unique position in sourcing new investments, even though the value of its portfolio was unchanged.
Derwent London: HSBC maintains Hold with a target price of 3053p.
Aviva: Macquarie upgrades to Hold with a target price of 534p.
Allied Minds, the life-science and technology intellectual property investor, has made Jill Smith's appointment as chief executive permanent, having hired her on an interim basis in March.
Domestically-focused UK stocks are unloved and underpriced, but unjustifiably so, analysts at Barclays Research believe, as they predict that recent outperformance by the group will run further.
Allied Minds' portfolio company, BridgeSat, has completed a $6m Series A funding round, including participation from Space Angels, an early stage investment group comprising experts in the Space 2.0 field.
Shares in Allied Minds tumbled on Wednesday after the US intellectual property firm said that it will restructure and reallocate capital and management resources across its portfolio, which will result in a $146m write-down in full year results, in order to accelerate commercialisation.
Allied Minds' co-founder and chief executive Chris Silva has stepped down with immediate effect and replaced in the short-term by non-executive director Jill Smith.
US science and technology developer Allied Minds is to form a new subsidiary, Signature Medical, to work with Boston University to develop a wearable device to monitor heart failure.
Science and technology investor Allied Minds has raised £64m ($81m) in an equity placing to increase investment in its portfolio of businesses and fund a pipeline of emerging technologies.
Allied Minds' subsidiary HawkEye 360 has raised $11m in new equity investment in a series A financing.
US science and technology developer Allied Minds has created a new subsidiary Vatic Materials, which has agreed to license certain materials technologies from Pennsylvania State University.